CHA
MRK icon

Cedar Hill Associates’s Merck MRK Stock Holding History

Cedar Hill Associates’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-6,415
Closed -$372K – 134
2018
Q2 		$372K Buy
6,415
+2,510
+64% +$142K 0.08% 119
2018
Q1 		$203K Sell
3,905
-1,899
-33% -$103K 0.04% 143
2017
Q4 		$312K Sell
5,804
-522
-8% -$28.9K 0.05% 123
2017
Q3 		$386K Buy
+6,326
New +$384K 0.07% 113

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Cedar Hill Associates's MRK Position: Q3 2018 in Review

Cedar Hill Associates sold out of Merck (MRK) in Q3 2018, closing a stake of 6,415 shares — an estimated $372K sold.

Cedar Hill Associates first reported a position in MRK in Q3 2017 and held it in 4 quarters. The position peaked at $386K in Q3 2017. 2,056 funds tracked by Wall St. Rank hold MRK as of Q3 2018.

  • Cedar Hill Associates reported no remaining Merck position as of Q3 2018 after selling out during the quarter.
  • Cedar Hill Associates sold 6,415 Merck shares in Q3 2018, an estimated $372K.
  • Cedar Hill Associates first reported a position in Merck in Q3 2017 and held it in 4 quarters.
  • Cedar Hill Associates's Merck position peaked at $386K in Q3 2017.
  • 2,056 funds tracked by Wall St. Rank held Merck as of Q3 2018.

Based on Cedar Hill Associates's 13F filing for Q3 2018, filed 23 Oct 2018.